نتایج جستجو برای: nonsmall cell lung cancer nsclc

تعداد نتایج: 2482650  

2013
Tsung-Ying Yang Gee-Chen Chang Shih-Lan Hsu Yi-Rou Huang Ling-Yen Chiu Gwo-Tarng Sheu

Pemetrexed (MTA) is a multitargeted antifolate drug approved for lung cancer therapy. Clinically, supplementation with high doses of folic acid (FA) and vitamin B12 (VB12) lowers MTA cytotoxicities. An antagonistic effect of FA/VB12 on MTA efficacy has been proposed. However, patients who receive FA/VB12 show better tolerance to MTA with improved survival. The aims of this study are to investig...

2017
Anant Mohan Rosemary Poulose Tarang Gupta Kalpana Luthra Ravindra M Pandey Karan Madan Vijay Hadda Randeep Guleria

BACKGROUND Lung cancer is associated with an oxidant-antioxidant imbalance that is implicated in tumor progression. However, the association of this imbalance on disease burden and treatment response is unclear. The effect of chemotherapy on oxidative stress, antioxidant status, and nutritional profile in patients with advanced nonsmall cell lung cancer (NSCLC) was prospectively evaluated. SU...

Journal: :International journal of cancer 2012
Xi Chen Zhibin Hu Wenjing Wang Yi Ba Lijia Ma Chunni Zhang Cheng Wang Zhiji Ren Yang Zhao Sijia Wu Rui Zhuang Yixin Zhang Heng Hu Chazhen Liu Lin Xu Jun Wang Hongbing Shen Junfeng Zhang Ke Zen Chen-Yu Zhang

The detection of nonsmall cell lung cancer (NSCLC) at an early stage presents a daunting challenge due to the lack of a specific noninvasive marker. The discovery of microRNAs (miRNAs), particularly those found in serum, has opened a new avenue for tumor diagnosis. To determine whether the expression profile of serum miRNAs can serve as a NSCLC fingerprint, we performed Taqman probe-based quant...

2013
Skye Hsin-Hsien Yeh Chien-Feng Lin Fan-Lin Kong Hsin-Ell Wang Ya-Ju Hsieh Juri G. Gelovani Ren-Shyan Liu

Mutations in the kinase domain of epidermal growth factor receptor (EGFR) have high levels of basal receptor phosphorylation and are associated with clinical responsiveness to Iressa in patients with nonsmall cell lung cancer (NSCLC). This study aimed to assess the feasibility of morpholino-[(124)I]IPQA derivative as an in vivo PET imaging tool for the expression of different EGFR mutants in NS...

2013
Angelina Cistaro Natale Quartuccio Alireza Mojtahedi Piercarlo Fania Pier Luigi Filosso Mariapaola Cucinotta Alfredo Campennì Umberto Ficola Sergio Baldari

PURPOSE To investigate the impact of the maximum standardized uptake value (SUVmax), size of primary lung lesion, and %ΔSUVmax on outcome (overall survival (OS) and 2-year disease-free survival (2-year DFS)) of patients with advanced nonsmall-cell lung cancer (NSCLC). MATERIALS AND METHODS 86 stage III-IV NSCLC patients underwent 18 F-FDGPET/CT, before and after chemotherapy, and were classif...

Journal: :Current opinion in oncology 2016
Anna Buder Christian Tomuta Martin Filipits

PURPOSE OF REVIEW This article discusses the current status and applications of liquid biopsy in nonsmall cell lung cancer (NSCLC). RECENT FINDINGS The discovery of genetic alterations which are responsible for the development and progression of NSCLC led to the identification of a new generation of molecular biomarkers. However, in NSCLC, it is often difficult in clinical practice to obtain ...

2014
Ruilin Xue Cuili Yang Fang Zhao Dejia Li

Aberrant methylation of CpG dinucleotides is a commonly observed epigenetic modification in human cancer. Thus, detection of aberrant gene promoter methylation as a tool for diagnosis of tumors or as a prognostic marker has been widely described for many types of cancers, including nonsmall cell lung cancer (NSCLC). Emerging evidence indicates that CDH13 is a candidate tumor suppressor in sever...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Christy C Ong Adrian M Jubb Peter M Haverty Wei Zhou Victoria Tran Tom Truong Helen Turley Tom O'Brien Domagoj Vucic Adrian L Harris Marcia Belvin Lori S Friedman Elizabeth M Blackwood Hartmut Koeppen Klaus P Hoeflich

p21-activated kinases (PAKs) are serine/threonine protein kinases that serve as important mediators of Rac and Cdc42 GTPase function as well as pathways required for Ras-driven tumorigenesis. PAK1 has been implicated in signaling by growth factor receptors and morphogenetic processes that control cell polarity, invasion, and actin cytoskeleton organization. To better understand the role of PAK1...

2016
Cairen Chen Weili Wang Qingyong Meng Ning Wu Jun Wei

A recent study reported that circulating antibodies to CD25-derived peptide antigens were significantly higher in patients with nonsmall cell lung cancer (NSCLC) than control subjects. The present study was, thus, undertaken to replicate the initial finding with different sample sets. An in-house ELISA was applied to determine circulating IgG antibodies to linear peptide antigens derived from C...

Journal: :European respiratory review : an official journal of the European Respiratory Society 2014
Lucio Crinò Giulio Metro

There is a major unmet medical need for effective and well-tolerated treatment options for patients with advanced nonsmall cell lung cancer (NSCLC), in both first-line and relapsed/refractory settings. Experimental evidence has validated signalling pathways that regulate tumour angiogenesis, including the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF) and fibro...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید